OverviewSuggest Edit

Elekta is a human care company that develops and sells clinical solutions for the cancer and brain disorder treatment. Its products are divided into four areas. Elekta Neuroscience, which develops solutions for the diagnosis and treatment of neurological diseases. Elekta Oncology, which creates clinical solutions for radiation therapy, such as linear accelerators, integrated imaging systems and clinical solutions for patient positioning and immobilization. Elekta Brachytherapy, that is engaged in the treatment of cancer through internal radiation. And Elekta Software, which develops software solutions for patient information, workflow management and treatment planning in oncology.

TypePublic
Founded1972
HQStockholm, SE
Websiteelekta.com
Employee Ratings3.2
Overall CultureB

Latest Updates

Employees (est.) (Nov 2020)4,000
Job Openings160
Share Price (Nov 2020)KR110.9
Cybersecurity ratingCMore

Key People/Management at Elekta

Karin Svenske

Karin Svenske

Executive Vice President, Human Resources
Birgitta Stymne Göransson

Birgitta Stymne Göransson

Board Member and Chairman of the Audit Committee
Ioannis Panagiotelis

Ioannis Panagiotelis

Chief Marketing and Sales Officer
Steven Wort

Steven Wort

COO
Paul Bergström

Paul Bergström

Executive Vice President , Global Services
Anming Gong

Anming Gong

Executive Vice President, Region China
Show more

Elekta Office Locations

Elekta has offices in Stockholm, Atlanta, North Sydney, Chennai and in 3 other locations
Stockholm, SE (HQ)
Kungstensgatan 18
North Sydney, AU
Suite 10.2, Level 10/146 Arthur St
Chennai, IN
D Silva Rd, Mylapore
Veenendaal, NL
Waardgelder 1
Cape Town, ZA
Kleinbron Estate
Crawley, GB
Linac House, Fleming Way
Show all (8)

Elekta Financials and Metrics

Elekta Revenue

Market capitalization (17-Nov-2020)

42.4b

Closing stock price (17-Nov-2020)

110.9
Elekta's current market capitalization is kr42.4 b.
Show all financial metrics

Elekta Cybersecurity Score

Cybersecurity ratingPremium dataset

C

74/100

SecurityScorecard logo

Elekta Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

Elekta Online and Social Media Presence

Embed Graph

Elekta Company Culture

  • Overall Culture

    B

    74/100

  • CEO Rating

    C+

    70/100

  • Compensation

    A

    83/100

  • Diversity

    A+

    91/100

Learn more on Comparably

Elekta News and Updates

Cyber Knife Market Next Big Thing | Major Giants- Accuray, Elekta, Nucletron, GE Healthcare

Stay up-to-date with Cyber Knife Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. Posted via Industry Today. Follow us on Twitter @IndustryToday

UPDATE 1-Sweden's Elekta profit margin tops guidance even as pandemic pain sets in

* CEO says seeing recovery in China (Adds detail, background)

Elekta Named one of the World's Most Ethical Companies by Ethisphere for the Second Time

STOCKHOLM, Feb. 26, 2020 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that they have been named one of the 2020 World's Most Ethical Companies® by Ethisphere, a global leader in defining and advancing the standards of ethical business practices. In 2020, 132 honorees were recognized...

Switzerland's Hôpital Riviera-Chablais Treats its First Patient With Elekta Unity MR-Linac

RENNAZ, Switzerland, Jan. 30, 2020 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced that Hôpital Riviera-Chablais in Rennaz has treated the first patient in Switzerland using Elekta Unity MR-Linac, a magnetic resonance radiation therapy (MR/RT) system that enables personalized precision...

China's HEDY Group Acquires 10 Elekta Cancer Treatment Systems

GUANGZHOU, China, Jan. 15, 2020 /PRNewswire/ -- Elekta (EKTA-B.ST) and HEDY Group of Guangzhou, China, recently signed an agreement for 10 linear accelerators (linacs) as well as Monaco® treatment planning, MOSAIQ® Oncology Information System and service for each of the linacs. HEDY group...

FDA Approves Diffusion-Weighted Images for Elekta Unity, Expanding Options for Assessment During Therapy

STOCKHOLM, Dec. 16, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced that it has received 510(k) premarket notification from the U.S. Food and Drug Administration for the use of diffusion-weighted MR images (DWI) obtained with Elekta Unity to be interpreted by a trained physician....
Show more

Elekta Blogs

Interim report, May–October 2020/21

Stable performance during Covid In Elekta's second quarter, we managed to perform better than the overall radiotherapy market both in terms of orders and revenue despite continuous challenging circumstances. We also improved margins and stabilized cash flow. The launch of our new Harmony linac and r…

Elekta early out in securing MDR certificates for its linac portfolio

Compliance with regulations benefits hospitals and patients by securing market access and avoiding disruption of product deliveries

Access to cancer treatment gets major boost in Mexico

San José Moscati Hospital and Elekta team up to equip new center with comprehensive range of radiotherapy solutions, including the groundbreaking Elekta Unity MR-Linac
Show more

Elekta Frequently Asked Questions

  • When was Elekta founded?

    Elekta was founded in 1972.

  • Who are Elekta key executives?

    Elekta's key executives are Karin Svenske, Birgitta Stymne Göransson and Ioannis Panagiotelis.

  • How many employees does Elekta have?

    Elekta has 4,000 employees.

  • Who are Elekta competitors?

    Competitors of Elekta include Accuray, Flatiron Health and Varian Medical Systems.

  • Where is Elekta headquarters?

    Elekta headquarters is located at Kungstensgatan 18, Stockholm.

  • Where are Elekta offices?

    Elekta has offices in Stockholm, Atlanta, North Sydney, Chennai and in 3 other locations.

  • How many offices does Elekta have?

    Elekta has 8 offices.